Scarica l'app Stockscreener
12.30
0.24%
-0.03
Dopo l'orario di chiusura:
12.27
-0.03
-0.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CDMO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$12.33
Aprire:
$12.31
Volume 24 ore:
1.02M
Relative Volume:
0.55
Capitalizzazione di mercato:
$786.75M
Reddito:
$139.91M
Utile/perdita netta:
$-140.75M
Rapporto P/E:
-273.94
EPS:
-0.0449
Flusso di cassa netto:
$-20.85M
1 W Prestazione:
-0.32%
1M Prestazione:
+0.65%
6M Prestazione:
+80.62%
1 anno Prestazione:
+98.39%
Intervallo 1D:
$12.29
$12.34
Intervallo di 1 settimana:
$12.28
$12.38
Portata 52W:
$5.65
$12.48
Avid Bioservices Inc Stock (CDMO) Company Profile
Nome
Avid Bioservices Inc
Settore
Industria
Telefono
714.508.6100
Indirizzo
14191 MYFORD ROAD, TUSTIN, CA
Confronta CDMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDMO
Avid Bioservices Inc
|
12.30 | 786.75M | 139.91M | -140.75M | -20.85M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Avid Bioservices Inc Stock (CDMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-09-28 | Iniziato | William Blair | Mkt Perform |
| 2023-03-14 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-03-17 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2019-12-10 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-17 | Iniziato | Stephens | Overweight |
| 2019-10-16 | Iniziato | Craig Hallum | Buy |
| 2019-06-28 | Aggiornamento | Janney | Neutral → Buy |
| 2019-05-09 | Downgrade | Janney | Buy → Neutral |
Mostra tutto
Avid Bioservices Inc Borsa (CDMO) Ultime notizie
Avid Bioservices Files Definitive Proxy Statement and Mails Letter to Stockholders - Marketscreener.com
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction - GlobeNewswire
Avid Bioservices Shareholders to Vote on $1.1B Buyout Deal at $12.50/Share Premium - StockTitan
Fmr LLC Increases Stake in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avid Bioservices, Inc. (CDMO) and Encourages Stockholders to Learn More About the Investigation - AccessWire
Lord Abbett & CO. LLC Takes $6.19 Million Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Avid Bioservices, Inc. (CDMO) Investors to Inquire about Securities Investigation - AccessWire
Avid Bioservices (CDMO) Can Exploit Potential U.S. BIOSECURE Act - MSN
Avid Bioservices' SWOT analysis: stock poised for private equity takeover By Investing.com - Investing.com Australia
GLAZER CAPITAL, LLC Acquires Significant Stake in Avid Bioservic - GuruFocus.com
Avid Bioservices' SWOT analysis: stock poised for private equity takeover - Investing.com India
Avid Bioservices: Fiscal Q2 Earnings Snapshot - CT Insider
Stephens keeps Avid Bioservices shares at Equal Weight on developments By Investing.com - Investing.com Canada
Avid Bioservices Reports Revenue Growth Amid Acquisition Plans - TipRanks
Vascular Disrupting Agents Market Top Companies StudyAGC - openPR
Avid Bioservices Reports Q2 Revenue of $33.5M, Misses Estimate; EPS at -$0.27, Wider Than Expected - GuruFocus.com
Avid Bioservices Inc. (CDMO) reports earnings - Quartz
Avid Bioservices, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 - Marketscreener.com
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024 - The Manila Times
Avid Bioservices earnings missed by $0.17, revenue fell short of estimates - Investing.com UK
Avid Bioservices Accepts $1.1B Buyout Offer as Q2 Revenue Surges 32% Despite Wider Losses - StockTitan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avid Bioservices, Inc. (CDMO) And Encourages Stockholders to Reach Out - AccessWire
(CDMO) On The My Stocks Page - Stock Traders Daily
Avid Bioservices (NASDAQ:CDMO) Stock Rating Lowered by Stephens - MarketBeat
Avid Bioservices gains as holder opposes $12.50 a share takeover - MSN
Point72 Asset Management L.P. Has $43.42 Million Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
CDMO (Avid Bioservices) EPS without NRI : $-2.27 (TTM As of Jul. 2024) - GuruFocus.com
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Avid Bioservices downgraded to Equal Weight from Overweight at Stephens - MSN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, BRKH, CTV, EMKR on Behalf of Shareholders - GlobeNewswire Inc.
Parkman Healthcare Partners LLC Boosts Stock Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Cinctive Capital Management LP Raises Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Cannell Capital to vote against Avid Biosciences takeover - MSN
Cannell Capital to vote against Avid Biosciences takeover (NASDAQ:CDMO) - Seeking Alpha
CDMO Investors Have the Opportunity to Join Investigation of Avid Bioservices, Inc. with the Schall Law Firm - Business Wire
Avid Bioservices (STU:TEHN) Forward Dividend Yield % : 0.00% (As of Nov. 30, 2024) - GuruFocus.com
CDMO (Avid Bioservices) GF Value Rank : 8 (As of Nov. 30, 2024) - GuruFocus.com
CDMO (Avid Bioservices) Cash Flow for Lease Financing : $0.0 Mil (TTM As of Jul. 2024) - GuruFocus.com
CDMO (Avid Bioservices) Enterprise Value : $958.0 Mil (As of Dec. 01, 2024) - GuruFocus.com
CDMO (Avid Bioservices) Other Long-Term Liabilities : $0.4 Mil (As of Jul. 2024) - GuruFocus.com
CDMO (Avid Bioservices) GF Value Rank : 8 (As of Nov. 29, 2024) - GuruFocus.com
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Fisher Asset Management LLC - MarketBeat
Analysts Set Avid Bioservices, Inc. (NASDAQ:CDMO) Price Target at $13.63 - Defense World
Avid Bioservices, Inc. (NASDAQ:CDMO) Receives $13.63 Consensus Target Price from Analysts - MarketBeat
Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand - MSN
Phocas Financial Corp. Purchases New Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Avid Bioservices' SWOT analysis: biomanufacturing stock faces acquisition, growth challenges - Investing.com Nigeria
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Royce & Associates LP - MarketBeat
Avid Bioservices, Inc. (CDMO): A Bull Case Theory - Insider Monkey
Janney Montgomery Scott LLC Buys 1,800 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
Avid Bioservices Inc Azioni (CDMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avid Bioservices Inc Azioni (CDMO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kwietniak Matthew R. | Chief Commercial Officer |
Oct 14 '24 |
Sale |
10.15 |
119 |
1,208 |
25,407 |
| Richieri Richard A. | Chief Operations Officer |
Oct 10 '24 |
Sale |
10.05 |
2,031 |
20,412 |
37,704 |
| Richieri Richard A. | Chief Operations Officer |
Oct 10 '24 |
Sale |
10.05 |
201 |
2,020 |
7,218 |
| Kwietniak Matthew R. | Chief Commercial Officer |
Oct 10 '24 |
Sale |
10.05 |
982 |
9,869 |
25,191 |
| Green Nicholas Stewart | President & CEO |
Oct 10 '24 |
Sale |
10.05 |
17,173 |
172,589 |
226,653 |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):